Stock Events

Stock Events

Nyxoah SA 

$1.6000
38
-$0.04-2.44% Friday 20:00
+$0.00+0%Friday 23:30After hours

Statistics

Day High
1.595
Day Low
1.595
52W High
6.88
52W Low
1.26
Volume
787
Avg. Volume
-
Mkt Cap
160.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.74
-0.61
-0.48
-0.35
Expected EPS
-0.35488904542
Actual EPS
N/A

Financials

-889.43%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
11.67MRevenue
-103.77MNet Income

Analyst Ratings

5.67Average Price Target
The highest estimate is 6.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NYXH. It's not an investment recommendation.
Microsoft
4
MSFT
NVIDIA
4
NVDA
Sequana medical NV
4
SEQUA.BR
Amazon
3
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Inspire Medical Systems
INSP
Mkt Cap1.65B
Inspire Medical Systems, Inc. offers an alternative obstructive sleep apnea treatment, directly competing with Nyxoah's hypoglossal nerve stimulation technology.
Medtronic
MDT
Mkt Cap116.83B
Medtronic plc provides various medical technologies, including sleep therapy devices that compete in the broader sleep apnea market.
Resmed
RMD
Mkt Cap32.38B
ResMed Inc. specializes in cloud-connectable medical devices for sleep apnea, directly competing in the sleep disorder market.
Koninklijke Philips N.V.
PHG
Mkt Cap26.67B
Koninklijke Philips N.V. offers sleep and respiratory care solutions, competing in the sleep apnea device market.
Zimmer Biomet
ZBH
Mkt Cap19.2B
Zimmer Biomet Holdings, Inc. is a competitor in the medical device sector, with products that can indirectly compete in the sleep apnea market.
Stryker
SYK
Mkt Cap130.11B
Stryker Corporation is involved in medical technologies, including products for sleep disorders, indirectly competing with Nyxoah.
Boston Scientific
BSX
Mkt Cap75.11B
Boston Scientific Corporation develops medical devices that, while not directly competing, offer alternative treatments in the broader market of sleep disorders.
Edwards Lifesciences
EW
Mkt Cap52.8B
Edwards Lifesciences Corporation is known for its patient-focused medical innovations, which include treatments that could indirectly compete in the sleep apnea space.
Abbott Laboratories
ABT
Mkt Cap192.51B
Abbott Laboratories offers a wide range of healthcare solutions, including devices for cardiovascular and neuromodulation, indirectly competing in the sleep disorder market.
Globus Medical
GMED
Mkt Cap11.53B
Globus Medical, Inc. is a medical device company that, while focusing on musculoskeletal solutions, competes in the broader medical device market against companies like Nyxoah.

About

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Show more...
CEO
Olivier Taelman
Employees
154
Country
Belgium
ISIN
BE0974358906
WKN
000A2QCWK

Listings

STU
DE
5YI.STU
MU
DE
5YI.MU
F
DE
5YI.F
BOATS
BOATS
NYXH.BOATS

0 Comments

Share your thoughts

FAQ

What is Nyxoah SA stock price today?▼
The current price of NYXH is $1.60 USD — it has decreased by -2.44% in the past 24 hours. Watch Nyxoah SA stock price performance more closely on the chart.
What is Nyxoah SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Nyxoah SA stocks are traded under the ticker NYXH.
Is Nyxoah SA stock price growing?▼
NYXH stock has fallen by -1.23% compared to the previous week, the month change is a +4.58% rise, over the last year Nyxoah SA has showed a -75.12% decrease.
What is Nyxoah SA market cap?▼
Today Nyxoah SA has the market capitalization of 160.12M
When is the next Nyxoah SA earnings date?▼
Nyxoah SA is going to release the next earnings report on November 05, 2026.
What were Nyxoah SA earnings last quarter?▼
NYXH earnings for the last quarter are -0.66 USD per share, whereas the estimation was -0.44 USD resulting in a -49.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nyxoah SA revenue for the last year?▼
Nyxoah SA revenue for the last year amounts to 11.67M USD.
What is Nyxoah SA net income for the last year?▼
NYXH net income for the last year is -103.77M USD.
How many employees does Nyxoah SA have?▼
As of August 22, 2026, the company has 154 employees.
In which sector is Nyxoah SA located?▼
Nyxoah SA operates in the Health & Wellness sector.
When did Nyxoah SA complete a stock split?▼
Nyxoah SA has not had any recent stock splits.
Where is Nyxoah SA headquartered?▼
Nyxoah SA is headquartered in Mont-Saint-Guibert, Belgium.